Intermolecular, Inc. provides thin film solutions. The Company's high productivity combinatorial (HPC) platform, which consists of its tempus processing tools, its automated characterization methods, and its Informatics analysis software, is purpose-built for research and development (R&D) using combinatorial process systems. It develops technology and Internet protocol (IP) rights focused on materials, processes, integration and device architectures in collaboration with its customers. Its HPC platform consists of tempus HPC processing, automated characterization and informatics and analysis software. The Company offers a series of wet processing tools and dry processing tools. Its informatics software includes workflow management software, analysis and reporting software, security and collaboration management software, and integration services. It caters to semiconductor device, semiconductor materials and equipment and clean energy market companies.
Industry, Sector and Symbol:
- Sector: Computer and Technology
- Industry: Semiconductors - NEC
- Sub-Industry: Semiconductors
- Symbol: NASDAQ:IMI
- CUSIP: 45882D10
- Web: www.intermolecular.com
Capitalization:- Market Cap: $45.6 million
- Outstanding Shares: 49,560,000
Average Prices:- 50 Day Moving Avg: $0.95
- 200 Day Moving Avg: $0.94
- 52 Week Range: $0.78 - $1.22
P/E:- Trailing P/E Ratio: N/A
- P/E Growth: 0.000
Sales & Book Value:- Annual Revenue: $42.73 million
- Price / Sales: 1.05
- Book Value: $0.80 per share
- Price / Book: 1.13
Profitability:- EBIDTA: ($6,230,000.00)
- Net Margins: -47.22%
- Return on Equity: -43.57%
- Return on Assets: -35.71%
Debt:- Current Ratio: 4.20%
- Quick Ratio: 4.20%
Misc:- Average Volume: 21,789 shs.
- Beta: 0.97
Frequently Asked Questions for Intermolecular (NASDAQ:IMI)
What is Intermolecular's stock symbol?
Intermolecular trades on the NASDAQ under the ticker symbol "IMI."
How were Intermolecular's earnings last quarter?
Intermolecular, Inc. (NASDAQ:IMI) released its quarterly earnings data on Thursday, February, 12th. The company reported ($0.10) EPS for the quarter, meeting the consensus estimate of ($0.10). The business had revenue of $11 million for the quarter, compared to the consensus estimate of $10.40 million. Intermolecular had a negative net margin of 47.22% and a negative return on equity of 43.57%. View Intermolecular's Earnings History.
Who are some of Intermolecular's key competitors?
Some companies that are related to Intermolecular include Nanoco Group PLC (NANO), eMagin (EMAN), Resonant (RESN), Netlist (NLST), ParkerVision (PRKR), Rubicon Technology (RBCN), MoSys (MOSY), Alent PLC (ALNT), Alliance Fiber Optic Products (AFOP), Altera (ALTR), Applied Micro Circuits (AMCC), ARM Holdings plc (ARM), ARM Holdings plc (ARMH), Atmel (ATML), Broadcom (BRCM), Exar (EXAR), EZchip Semiconductor Ltd (EZCH) and Fairchild Semiconductor Intl (FCS).
Who are Intermolecular's key executives?
Intermolecular's management team includes the folowing people:
- Bill Roeschlein, Chief Financial Officer, Principal Financial & Principal Accounting Officer
- Bruce M. McWilliams Ph.D., Non-Executive Chairman of the Board
- Matthew Furnas, Director
- Christian F. Kramer, Director
- Marvin D. Burkett, Independent Director
- Irwin B. Federman, Independent Director
Who owns Intermolecular stock?
Intermolecular's stock is owned by a variety of of retail and institutional investors. Top institutional investors include Symmetry Peak Management LLC (2.06%), Vanguard Group Inc. (1.03%) and Royce & Associates LP (0.56%). Company insiders that own Intermolecular stock include Irwin Federman, Lloyd I Miller III, Rick Neely and William C Martin. View Institutional Ownership Trends for Intermolecular.
Who sold Intermolecular stock? Who is selling Intermolecular stock?
How do I buy Intermolecular stock?
Shares of Intermolecular can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Intermolecular's stock price today?
One share of Intermolecular stock can currently be purchased for approximately $0.91.
MarketBeat Community Rating for Intermolecular (NASDAQ IMI)MarketBeat's community ratings are surveys of what our community members think about Intermolecular and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.
Consensus Ratings for Intermolecular (NASDAQ:IMI) (How are Consensus Ratings Calculated?) MarketBeat calculates consensus ratings using the most recent rating from each brokerage that has rated a stock within the last twelve months. Since brokers often use different ratings systems, each rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings. Each stock's consensus rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months.
MarketBeat will no longer include ratings and price target data in its consensus calculation if a broker drops coverage and MarketBeat has received a report that coverage was dropped. Ratings from certain research firms that issue ratings using purely quantitative methods (such as Zacks, Vetr and ValuEngine) are not included in consensus calculations. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
| Ratings Breakdown: | 1 Hold Rating |
| Consensus Rating: | Hold (Score: 2.00) |
| Consensus Price Target: | N/A |
Analysts' Ratings History for Intermolecular (NASDAQ:IMI)
Show:
| Date | Firm | Action | Rating | Price Target | Impact on Share Price | Details |
|---|
| 2/16/2017 | Needham & Company LLC | Reiterated Rating | Hold | | N/A |  |
| 9/29/2015 | Northland Securities | Upgrade | Market Perform -> Outperform | $2.22 -> $3.00 | N/A | |
(Data available from 8/16/2015 forward)
Earnings History for Intermolecular (NASDAQ:IMI)Earnings History by Quarter for Intermolecular (NASDAQ IMI)| Date | Quarter | Consensus Estimate | Actual EPS | Revenue Estimate | Actual Revenue | Release Link | Conference Call | Details |
|---|
| 2/9/2017 | Q416 | ($0.08) | ($0.05) | $10.20 million | $10.50 million | View | Listen | |
| 2/12/2015 | Q414 | ($0.10) | ($0.10) | $10.40 million | $11.00 million | View | N/A | |
| 10/31/2014 | Q314 | ($0.09) | ($0.07) | $10.60 million | $10.90 million | View | N/A | |
| 8/1/2014 | Q2 2014 | ($0.19) | ($0.14) | $9.00 million | $9.93 million | View | N/A | |
| 5/6/2014 | Q1 | ($0.05) | ($0.06) | $15.51 million | $15.91 million | View | N/A | |
| 2/6/2014 | | ($0.07) | ($0.07) | $15.57 million | $15.60 million | View | N/A | |
| 2/6/2014 | | ($0.07) | ($0.07) | $15.57 million | $15.60 million | View | N/A | |
| 2/6/2014 | Q413 | ($0.07) | ($0.07) | $15.57 million | $15.60 million | View | N/A | |
| 10/24/2013 | Q313 | ($0.03) | ($0.05) | $15.50 million | $17.70 million | View | N/A | |
| 7/25/2013 | Q213 | ($0.01) | $0.01 | $16.54 million | $16.60 million | View | N/A | |
| 4/25/2013 | Q1 2013 | | $0.03 | $16.97 million | $17.43 million | View | N/A | |
| 2/7/2013 | Q4 2013 | $0.01 | $0.03 | $16.68 million | $17.40 million | View | N/A | |
| 10/25/2012 | | ($0.03) | $0.02 | | | View | N/A | |
| 7/26/2012 | | ($0.03) | ($0.02) | | | View | N/A | |
(Data available from 1/1/2011 forward)
Earnings Estimates for Intermolecular (NASDAQ:IMI)No earnings estimates for this company have been tracked by MarketBeat.com
Dividend History for Intermolecular (NASDAQ:IMI)
No dividend announcements for this company have been tracked by MarketBeat.com
Insider Trading and Institutional Ownership History for Intermolecular (NASDAQ:IMI)Insider Ownership Percentage: 15.20%
Institutional Ownership Percentage: 38.87%
Insider Trades by Quarter for Intermolecular (NASDAQ:IMI)| Transaction Date | Insider Name | Title | Buy/Sell | Number of Shares | Average Share Price | Total Transaction | Details |
|---|
| 6/22/2017 | Lloyd I Miller III | Major Shareholder | Buy | 80,000 | $0.88 | $70,400.00 | |
| 6/20/2017 | Lloyd I Miller III | Major Shareholder | Buy | 6,659 | $0.86 | $5,726.74 | |
| 5/24/2017 | Lloyd I Miller III | Major Shareholder | Buy | 107 | $0.85 | $90.95 | |
| 5/23/2017 | Lloyd I Miller III | Major Shareholder | Buy | 29,020 | $0.85 | $24,667.00 | |
| 5/22/2017 | Lloyd I Miller III | Major Shareholder | Buy | 5,590 | $0.85 | $4,751.50 | |
| 5/19/2017 | Lloyd I Miller III | Major Shareholder | Buy | 6,564 | $0.85 | $5,579.40 | |
| 5/18/2017 | Lloyd I Miller III | Major Shareholder | Buy | 2,132 | $0.85 | $1,812.20 | |
| 5/17/2017 | Lloyd I Miller III | Major Shareholder | Buy | 12,743 | $0.85 | $10,831.55 | |
| 5/16/2017 | Lloyd I Miller III | Major Shareholder | Buy | 9,325 | $0.85 | $7,926.25 | |
| 5/15/2017 | Lloyd I Miller III | Major Shareholder | Buy | 8,817 | $0.85 | $7,494.45 | |
| 5/12/2017 | Lloyd I Miller III | Major Shareholder | Buy | 4,642 | $0.85 | $3,945.70 | |
| 2/28/2017 | Rick Neely | CFO | Sell | 1,145 | $1.02 | $1,167.90 | |
| 12/16/2016 | William C Martin | Major Shareholder | Buy | 214,294 | $1.02 | $218,579.88 | |
| 11/18/2016 | William C Martin | Major Shareholder | Buy | 400 | $1.00 | $400.00 | |
| 11/17/2016 | William C Martin | Major Shareholder | Buy | 990,452 | $0.85 | $841,884.20 | |
| 10/14/2016 | Rick Neely | CFO | Sell | 4,586 | $0.95 | $4,356.70 | |
| 8/15/2016 | Irwin Federman | Director | Buy | 100,000 | $1.25 | $125,000.00 | |
| 8/12/2016 | William C Martin | Major Shareholder | Buy | 10,944 | $1.25 | $13,680.00 | |
| 8/11/2016 | William C Martin | Major Shareholder | Buy | 2,165,634 | $1.02 | $2,208,946.68 | |
| 5/17/2016 | Irwin Federman | Director | Buy | 100,000 | $1.90 | $190,000.00 | |
| 3/1/2016 | Rick Neely | CFO | Sell | 940 | $2.18 | $2,049.20 | |
| 2/24/2016 | Irwin Federman | Director | Buy | 5,900 | $2.12 | $12,508.00 | |
| 2/16/2016 | Irwin Federman | Director | Buy | 4,716 | $2.12 | $9,997.92 | |
| 2/11/2016 | Irwin Federman | Director | Buy | 17,878 | $2.10 | $37,543.80 | |
| 12/9/2015 | Irwin Federman | Director | Buy | 5,603 | $2.05 | $11,486.15 | |
| 12/8/2015 | Irwin Federman | Director | Buy | 1,600 | $2.04 | $3,264.00 | |
| 12/7/2015 | Irwin Federman | Director | Buy | 200 | $2.05 | $410.00 | |
| 11/17/2015 | Irwin Federman | Director | Buy | 4,600 | $2.03 | $9,338.00 | |
| 11/16/2015 | Irwin Federman | Director | Buy | 64,300 | $2.00 | $128,600.00 | |
| 10/5/2015 | Rick Neely | CFO | Sell | 3,807 | $1.86 | $7,081.02 | |
| 9/23/2015 | William C Martin | Major Shareholder | Buy | 283,913 | $1.75 | $496,847.75 | |
| 6/25/2015 | Rick Neely | CFO | Sell | 33,407 | $1.95 | $65,143.65 | |
| 11/13/2014 | Irwin Federman | Director | Buy | 50,000 | $2.14 | $107,000.00 | |
| 11/4/2014 | Irwin Federman | Director | Buy | 100,000 | $2.25 | $225,000.00 | |
| 10/3/2014 | Rick Neely | CFO | Sell | 3,884 | $2.31 | $8,972.04 | |
| 7/29/2014 | Hector Thomas Blanco | VP | Sell | 3,032 | $2.24 | $6,791.68 | |
| 7/23/2014 | Hector Thomas Blanco | VP | Sell | 1,968 | $2.20 | $4,329.60 | |
| 5/1/2014 | Sandeep Jaggi | SVP | Sell | 5,569 | $2.70 | $15,036.30 | |
| 3/31/2014 | Raj Jammy | SVP | Sell | 5,356 | $2.76 | $14,782.56 | |
| 3/3/2014 | Tony Chiang | CTO | Sell | 1,476 | $2.64 | $3,896.64 | |
| 2/6/2014 | David Lazovsky | CEO | Sell | 4,552 | $4.02 | $18,299.04 | |
| 1/28/2014 | Sandeep Jaggi | SVP | Sell | 2,322 | $4.06 | $9,427.32 | |
| 1/28/2014 | Sandeep Nijhawan | VP | Sell | 4,064 | $4.06 | $16,499.84 | |
| 1/28/2014 | Tony Chiang | CTO | Sell | 1,742 | $4.06 | $7,072.52 | |
| 12/10/2013 | David Lazovsky | CEO | Sell | 38,500 | $5.33 | $205,205.00 | |
| 12/4/2013 | Tony Chiang | CTO | Sell | 30,000 | $5.52 | $165,600.00 | |
| 11/8/2013 | David Lazovsky | CEO | Sell | 38,500 | $5.58 | $214,830.00 | |
| 10/8/2013 | David Lazovsky | CEO | Sell | 38,500 | $5.80 | $223,300.00 | |
| 9/9/2013 | David E Lazovsky | CEO | Sell | 38,500 | $5.89 | $226,765.00 | |
| 9/5/2013 | Tony Chiang | CTO | Sell | 39,003 | $5.97 | $232,847.91 | |
| 8/7/2013 | David Lazovsky | CEO | Sell | 38,500 | $6.20 | $238,700.00 | |
| 8/1/2013 | Tony P Chiang | CTO | Sell | 48,000 | $6.31 | $302,880.00 | |
| 7/16/2013 | Peter L Eidelman | CFO | Sell | 21,753 | $6.96 | $151,400.88 | |
| 7/8/2013 | David E Lazovsky | CEO | Sell | 38,500 | $7.34 | $282,590.00 | |
| 7/3/2013 | Tony P Chiang | CTO | Sell | 78,000 | $7.23 | $563,940.00 | |
| 6/17/2013 | Peter L Eidelman | CFO | Sell | 6,500 | $7.30 | $47,450.00 | |
| 6/7/2013 | David E Lazovsky | CEO | Sell | 38,500 | $8.22 | $316,470.00 | |
| 6/3/2013 | James Craig Hunter | SVP | Sell | 3,500 | $8.43 | $29,505.00 | |
| 5/23/2013 | Tony P Chiang | CTO | Sell | 52,926 | $8.40 | $444,578.40 | |
| 5/16/2013 | Peter L Eidelman | CFO | Sell | 6,500 | $8.68 | $56,420.00 | |
| 3/25/2013 | Tony P Chiang | CTO | Sell | 25,000 | $9.53 | $238,250.00 | |
| 2/26/2013 | Tony P Chiang | CTO | Sell | 72,612 | $9.55 | $693,444.60 | |
| 2/21/2013 | Bruce M Mcwilliams | Director | Sell | 2,132 | $9.64 | $20,552.48 | |
| 1/17/2013 | Bruce M Mcwilliams | Director | Sell | 21,200 | $9.27 | $196,524.00 | |
| 12/3/2012 | John R Behnke | SVP | Sell | 2,500 | $6.99 | $17,475.00 | |
| 10/8/2012 | David E Lazovsky | CEO | Sell | 26,810 | $7.23 | $193,836.30 | |
| 9/5/2012 | James Craig Hunter | SVP | Sell | 3,500 | $7.20 | $25,200.00 | |
| 8/23/2012 | Tony P Chiang | CTO | Sell | 14,266 | $7.15 | $102,001.90 | |
(Data available from 1/1/2013 forward)
Headline Trends for Intermolecular (NASDAQ:IMI)
Latest Headlines for Intermolecular (NASDAQ:IMI)
| Source: |
|
| Date | Headline |
|---|
 | Edited Transcript of IMI earnings conference call or presentation 8-Aug-17 9:00pm GMT
finance.yahoo.com - August 9 at 5:34 AM |
| Intermolecular Announces Second Quarter 2017 Financial Results
finance.yahoo.com - August 8 at 7:30 PM |
 | Intermolecular Inc (IMI) Upgraded to Sell at ValuEngine
www.americanbankingnews.com - August 7 at 11:50 PM |
| Intermolecular's High-Throughput Experimentation Platform Speeds Discovery of Next-Generation Non-Volatile Memories
finance.yahoo.com - August 1 at 3:25 PM |
| Intermolecular To Report Second Quarter Fiscal 2017 Financial Results on August 8, 2017
finance.yahoo.com - July 14 at 3:50 AM |
| Lloyd I. Miller III Acquires 80,000 Shares of Intermolecular, Inc. (IMI) Stock
www.americanbankingnews.com - June 23 at 5:08 PM |
| ETFs with exposure to Intermolecular, Inc. : May 25, 2017
finance.yahoo.com - May 26 at 2:17 AM |
| Lloyd I. Miller III Buys 29,020 Shares of Intermolecular Inc (IMI) Stock
www.americanbankingnews.com - May 24 at 1:24 PM |
| Intermolecular Inc (IMI) Major Shareholder Acquires $10,831.55 in Stock
www.americanbankingnews.com - May 18 at 4:54 PM |
| ETFs with exposure to Intermolecular, Inc. : May 11, 2017
finance.yahoo.com - May 11 at 6:29 PM |
| Intermolecular, Inc. :IMI-US: Earnings Analysis: Q1, 2017 By the Numbers : May 10, 2017
finance.yahoo.com - May 10 at 1:20 PM |
| Edited Transcript of IMI earnings conference call or presentation 4-May-17 9:00pm GMT
finance.yahoo.com - May 5 at 5:52 PM |
| Somewhat Favorable News Coverage Very Likely to Impact Intermolecular (IMI) Stock Price
www.americanbankingnews.com - May 4 at 8:52 PM |
 | Intermolecular reports 1Q loss
marketbeat.com - May 4 at 7:57 PM |
| Investor Network: Intermolecular, Inc. to Host Earnings Call
finance.yahoo.com - May 4 at 6:04 PM |
| Intermolecular Announces First Quarter 2017 Financial Results
finance.yahoo.com - May 4 at 6:04 PM |
| Intermolecular (IMI) Getting Somewhat Positive News Coverage, Report Shows
www.americanbankingnews.com - May 1 at 7:32 PM |
| Somewhat Favorable Media Coverage Extremely Likely to Affect Intermolecular (IMI) Share Price
www.americanbankingnews.com - April 27 at 3:36 PM |
| Intermolecular (IMI) Earning Positive News Coverage, Analysis Shows
www.americanbankingnews.com - April 24 at 1:32 PM |
| Intermolecular (IMI) Earning Favorable Media Coverage, Report Shows
www.americanbankingnews.com - April 20 at 11:09 AM |
| Intermolecular (IMI) Given Daily Coverage Optimism Rating of 0.23
www.americanbankingnews.com - April 17 at 11:51 PM |
| Intermolecular (IMI) Earns Coverage Optimism Rating of 0.03
www.americanbankingnews.com - April 14 at 6:52 PM |
| Intermolecular To Report First Quarter Fiscal 2017 Financial Results on May 4, 2017
finance.yahoo.com - April 13 at 5:38 PM |
| ETFs with exposure to Intermolecular, Inc. : April 7, 2017
finance.yahoo.com - April 7 at 5:46 PM |
 | Intermolecular Announces Restructuring Initiative and Changes in its Leadership Team
us.rd.yahoo.com - March 29 at 6:25 PM |
| 4:18 pm Intermolecular appoints Bill Roeschlein, currently VP of Finance and Corporate Controller, as CFO; also announces restructuring initiative that will lower costs by approx. $4 mln in 2017
us.rd.yahoo.com - March 29 at 6:25 PM |
| INTERMOLECULAR INC Files SEC form 8-K, Costs Associated with Exit or Disposal Activities, Change in Directors or Prin
biz.yahoo.com - March 29 at 6:25 PM |
| INTERMOLECULAR INC Files SEC form 10-K, Annual Report
biz.yahoo.com - March 3 at 5:53 PM |
| Q4 2016 Intermolecular Inc Earnings Release - After Market Close
us.rd.yahoo.com - February 10 at 6:39 PM |
| INTERMOLECULAR INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibi
us.rd.yahoo.com - February 10 at 6:39 PM |
| Edited Transcript of IMI earnings conference call or presentation 9-Feb-17 10:00pm GMT
finance.yahoo.com - February 10 at 6:39 PM |
 | Intermolecular Announces Fourth Quarter 2016 and Full Year 2016 Financial Results
www.bizjournals.com - February 9 at 6:49 PM |
| POET Technologies Appoints David Lazovsky as Executive Chairman of Board
finance.yahoo.com - February 1 at 6:39 PM |
| Intermolecular To Report Fourth Quarter and Fiscal Year 2016 Financial Results on February 9, 2017
finance.yahoo.com - January 12 at 6:22 PM |
| INTERMOLECULAR INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and Exhibits
biz.yahoo.com - November 16 at 5:52 PM |
| Edited Transcript of IMI earnings conference call or presentation 2-Nov-16 9:00pm GMT
finance.yahoo.com - November 3 at 5:34 PM |
 | Intermolecular Announces Third Quarter 2016 Financial Results
www.prnewswire.com - November 2 at 5:50 PM |
| Q3 2016 Intermolecular Inc Earnings Release - After Market Close
biz.yahoo.com - November 2 at 9:02 AM |
| Intermolecular To Report Third Quarter Fiscal 2016 Financial Results on November 2, 2016
finance.yahoo.com - October 13 at 5:38 PM |
| INTERMOLECULAR INC Files SEC form 8-K, Change in Directors or Principal Officers
biz.yahoo.com - September 23 at 8:34 AM |
| INTERMOLECULAR INC Financials
finance.yahoo.com - August 13 at 5:26 PM |
| Intermolecular to Present at 2016 Flash Memory Summit on How High-Throughput Experimentation Can Identify …
finance.yahoo.com - August 10 at 5:54 PM |
| Intermolecular, Inc. (IMI)
finance.yahoo.com - August 6 at 5:49 PM |
| Edited Transcript of IMI earnings conference call or presentation 4-Aug-16 9:00pm GMT
finance.yahoo.com - August 6 at 5:49 PM |
 | Unusual 11 Mid-Day Movers 8/5: (LNTH) (PTCT) (WLDN) Higher; (CPSI) (HDP) (IMI) Lower
www.streetinsider.com - August 5 at 5:45 PM |
| Q2 2016 Intermolecular Inc Earnings Release - After Market Close
biz.yahoo.com - August 4 at 8:38 AM |
| 3:18 am Intermolecular to present its High-Throughput Experimentation Platform and State-of-the-Art ALD Technology; combinatorial ALD hardware to study H2O2 as alternate oxidant for metal oxide deposition
finance.yahoo.com - July 25 at 3:18 AM |
| INTERMOLECULAR INC Files SEC form 8-K, Submission of Matters to a Vote of Security Holders
biz.yahoo.com - May 27 at 4:46 PM |
| SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces an Investigation Involving Possible Breaches of Fiduciary Duty by the Board of Intermolecular, Inc. - IMI
finance.yahoo.com - April 20 at 11:35 AM |
| Purcell Julie & Lefkowitz LLP Is Investigating Intermolecular, Inc. for Potential Breaches Of Fiduciary Duty By Its Board of Directors
finance.yahoo.com - April 20 at 9:41 AM |
Intermolecular (IMI) Chart for Wednesday, August, 16, 2017
